Abstract:BACKGROUND:ERBB3 binding protein 1 (EBP1) gene transfer into human salivary adenoid cystic carcinoma cells has been shown to significantly inhibit cell proliferation and reduce tumor metastasis in mouse models. In the current study, to evaluate if EBP1 is a novel biomarker capable of identifying patients at higher risk of disease progression and recurrence, we examined the EBP1 expression profile in adenoid cystic carcinoma (ACC) patients and analyzed its clinicopathological relevance. To understand the underlying anti-metastatic mechanism, we investigated if EBP1 regulates invasion-related molecules.METHODS:We performed immunohistochemical analysis on 132 primary adenoid cystic carcinoma and adjacent non-cancerous tissues using commercial EBP1, MMP9, E-cadherin and ICAM-1 antibodies. Results were correlated to clinicopathological parameters, long-term survival and invasion-related molecules by statistical analysis. Cell motility and invasiveness of vector or wild-type EBP1-transfected ACC-M cell lines were evaluated using wound healing and Boyden chamber assays. MMP9, E-cadherin and ICAM-1 proteins in these cell lines were detected using western blot assay.RESULTS:The expression of EBP1 was significantly higher in non-cancerous adjacent tissues compared with corresponding cancer tissues. The intensity and percentage of cells that reacted with EBP1 antibodies were significantly higher in cases with tubular pattern than those with solid pattern (P<0.0001). We also found adenoid cystic carcinoma with local lymphatic metastasis had significantly lower EBP1 expression than ACC with no local lymphatic node metastasis (P<0.0001). Similar findings were observed in ACC with lung metastasis compared with cases with no lung metastasis (P<0.0001), in particular, in cases with perineural invasion compared with cases with no perineural invasion (P<0.0001). Furthermore, a decrease in EBP1 expression was positively associated with a reduction in overall survival of ACC patients. Of note, EBP1 inhibits migration and invasiveness of ACC cells by upregulating E-cadherin but downregulating MMP9. In clinical adenoid cystic carcinoma patients, higher EBP1 expression was positively correlated with E-cadherin levels (P<0.001) but negatively correlated with MMP9 expression (P=0.0002).CONCLUSIONS:EBP1 expression is reduced in adenoid cystic carcinoma, indicating unfavorable prognosis of ACC patients. Its regulation of MMP9 and E-cadherin protein levels suggests a critical therapeutic potential.

Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.

Promoter Hypermethylation May Contribute to E‑cadherin Repression in the Human Salivary Carcinoma Ex Pleomorphic Adenoma

Methylation of E-cadherin, p16, RASSF1A, DAPK and MGMT in salivary gland tissues

Methylation of Five Tumor Suppressor Genes and Their Expression in Salivary Adenoid Cystic Carcinoma Cell Lines

Promoter Methylation Regulates Cadherin Switching in Squamous Cell Carcinoma

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

Promoter-hypermethylation Associated Defective Expression of E-cadherin in Primary Non-Small Cell Lung Cancer.

Rassf1a Promoter Hypermethylation Is A Strong Biomarker Of Poor Survival In Patients With Salivary Adenoid Cystic Carcinoma In A Chinese Population

CDH1 Gene Methylation and E-cadherin in Salivary Malignant Pleomorphic Adenoma

Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes]

Clinical outcomes of downregulation of E-cadherin gene expression in non-small cell lung cancer.

Expression of ERBB3 Binding Protein 1 (EBP1) in Salivary Adenoid Cystic Carcinoma and Its Clinicopathological Relevance.

The Study on Promoter Methylation Status of E-cadherin Gene in Cutaneous Squamous Cell Carcinoma

Aberrant Promoter Methylation of T-cadherin in Sera is Associated with a Poor Prognosis in Oral Squamous Cell Carcinoma

INFREQUENTLY METHYLATED EVENT AT SITES −181 TO −9 WITHIN THE 5′ CpG ISLAND OF<i>E-CADHERIN</i>IN NON-SMALL CELL LUNG CANCER

Promoter Hypermethylation of Rassf1a Is A Predictor for Poor Survival of Patients with Salivary Adenoid Cystic Carcinoma In A Chinese Population

The Expression of MACC1 and Its Role in the Proliferation and Apoptosis of Salivary Adenoid Cystic Carcinoma.

METHYLATION OF GENE E-CADHERIN AND ITS EXPRESSION IN GASTRIC CARCINOMAS

Transcriptome Analyses Identify Hub Genes and Potential Mechanisms in Adenoid Cystic Carcinoma.

Expression and Clinical Significance of ErbB3 Binding Protein Ebp1, E-cadherin, ICAM-1 and Matrix Metalloproteinase-9 in Salivary Adenoid Cystic Carcinoma

EGFR Activation Induced Snail-dependent EMT and Myc-Dependent PD-L1 in Human Salivary Adenoid Cystic Carcinoma Cells.